Innate immunity in multiple sclerosis: Myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response

Journal of Immunology

Volumn 177, Issue 6, 2006, Pages 4196-4202

  Karni, Arnon ^a,b   Abraham, Michal ^a   Monsonego, Alon ^a   Cai, Guifang ^a   Freeman, Gordon J ^a   Hafler, David ^a   Khoury, Samia J ^a   Weiner, Howard L ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; PD L1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; PRIORITY JOURNAL; RELAPSE; REMISSION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 33748510173     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.6.4196     Document Type: Article

References (44)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. 4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
3. Legge, K. L., R. K. Gregg, R. Maldonado-Lopez, L. Li, J. C. Caprio, M. Moser, and H. Zaghouani. 2002. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196: 217-227.
4. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99: 351-358.
5. Blanco, P., A. K. Patacka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543.
6. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747.
7. Imitola J., T. Chitnis and S. J. Khoury. 2006. Insights into the molecular parthogenesis of progression in multiple sclerosis: potential implications for future therapies. Arch. Neurol. 63: 25-33.
8. + T cells are increased in multiple sclerosis and their ligands MIP-α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96: 6873-6787.
9. Balashov, K. E., M. Comabella, T. Ohashi, S. J. Khoury, and H. L. Weiner. 2000. Defective regulation of IFN-γ and IL-12 endogenous IL-10 in progressive MS. Neurology 55: 192-198.
10. Vaknin-Dembinsky, A., K. Balashov, and H. L. Weiner. 2006. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 produciton. J. Immunol. 176: 1768-1774.
11. + T-cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 94: 599-603.
12. + T cells via CD40-CD40 ligand interactions. J. Neuroimmunol. 125: 134-140.
13. Huang, Y. M., B. G. Xiao, V. Ozenci, M. Kouwenhoven, N. Teleshova, S. Fredrikson, and H. Link. 1999. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J. Neuroimmunol. 99: 82-90.
14. +) blood dendritic cells in multiple sclerosis and acute optic neuritis. Clin. Exp. Immunol. 127: 519-526.
15. Moody, M. D., S. W. Van Arsdell, K. P. Murphy, S. F. Orencole, and C. Burns. 2001. Array-based ELISAs for high-throughput analysis of human cytokines. BioTechniques 31: 186-190.
16. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
17. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhance T-cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752.
18. Alexandroff, A. B., A. M. Jackson, T. Paterson, J. L. Haley, J. A. Ross, D. L. Longo, W. J. Murphy, K. James, and D. D. Taub. 2000. Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol. Immunol. 37: 515-526.
19. Kuchroo, V., M. Prabhu Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
20. Kouwenhoven, M., N. Teleshova, V. Ozenci, R. Press, and H. Link. 2001. Monocytes in multiple sclerosis: phenotype and cytokine profile. J. Neuroimmunol. 112: 197-205.
21. Lindgren, H., K. Axcrona, and T. Leanderson. 2001. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2. J. Immunol. 166: 4578-4585.
22. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
23. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
24. Weiner, H. L. 2004. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol. 61: 1613-.
25. Pette, M., K. Fujita, B. Kitze, J. N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40: 1770-1776.
26. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. L. Weiner, and D. A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179: 973-984.
27. Kerlero de Rosbo, N., M. Hoffman, I. Mendel, I. Yust, J. Kaye, R. Bakimer, S. Flechter, O. Abramsky, R. Milo, A. Karni, and A. Ben-Nun. 1997. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur. J. Immunol. 27: 3059-3069.
28. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
29. Bjartmar, C., J. R. Wujek, and B. D. Trapp. 2003. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206: 165-171.
30. Kutzelnigg, A., C. F. Lucchinetti, C. Stadelmann, W. Bruck, H. Rauschka, M. Bergmann, M. Schmidbauer, J. E. Parisi, and H. Lassmann. 2005. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128: 2705-2712.
31. Gauthier, S., B. I. Glanz, M. Mandel, and H. L. Weiner. 2006. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. Autoimmun. Rev. In press.
32. Rossi, M., and J. W. Young. 2005. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 175: 1373-1381.
33. Grouard, G., M. C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y. J. Liu. 1997. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185: 1101-1111.
34. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D. W. Buck, and J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165: 6037-6046.
35. + regulatory T cells. J. Immunol. 173: 4433-4442.
36. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
37. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5: 919-923.
38. Bamford, C. R., W. A. Sibley, and C. Thies. 1983. Seasonal variation of multiple sclerosis exacerbations in Arizona. Neurology 33: 697-701.
39. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with γ interferon. Lancet 1: 893-895.
40. Serafini, B., S. Columba-Cabezas, F. Di Rosa, and F. Aloisi. 2000. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157: 1991-2002.
41. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334.
42. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335-339.
43. Serafini, B., B. Rosicarelli, R. Magliozzi, E. Stigliano, E. Capello, G. L. Mancardi, and F. Aloisi. 2006. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65: 124-141.
44. Polman, C. H., P. W. O'Connor, E. Havrdova, M. Hutchinson, L. Kappos, D. H. Miller, J. T. Phillips, F. D. Lublin, G. Giovannoni, A. Wajgt, et al. 2006. A randomized, placebo-controlled trail of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354: 899-910.